Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-13
1999-11-02
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546187, 546188, A61K 31445, C07D40104
Patent
active
059771380
ABSTRACT:
1,4 Di-substituted piperidine muscarinic antagonists of formula I ##STR1## or an isomer, pharmaceutically acceptable salt, ester or solvate thereof, wherein
REFERENCES:
patent: 3260723 (1966-07-01), L'Italien et al.
patent: 5100901 (1992-03-01), Sugimoto et al.
patent: 5580883 (1996-12-01), Goto et al.
patent: 5652242 (1997-07-01), Wayne et al.
Baumgold et al, Eur. J. Pharmacol., 251 (1994), pp. 315-317.
Melchiorre et al, J. Med. Chem., 36 (1993), pp. 3734-3737.
Logemann et al, Brit. J. Pharmacol., 17 (1961), pp. 286-296.
Cheng et al, Biochem. Pharmacol., 22 (1973), pp. 3099-3108.
Watson et al, J. Pharmacol. Exp. Ther., 237 (1986), pp. 411-418.
Sindelar, et al., Collect. Czech Chem. Commun., 54 (8) (1989), pp. 2240-2247.
Parnetti, L., Clinical Pharmacokinetics, 29 (2) (1995), pp. 110-129, abstract only.
Chackalamannil Samuel
Chang Wei K.
Dugar Sundeep
Wang Yuguang
Aulakh Charanjit S
Magatti Anita W.
Rotman Alan L.
Schering Corporation
LandOfFree
Ether muscarinic antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ether muscarinic antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ether muscarinic antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135873